ArticleVaccines2022

Response to Omalizumab as an Add-On Therapy in the Treatment of Allergic Asthma in Adult Chinese Patients-A Retrospective Study.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.